<-- Back to proposed bills

Covid-19 Update

12 January 2022

Proposing MP
Bromsgrove
Type
Written Ministerial Statement
Department
Department of Health and Social Care

At a Glance

Issue Summary

The statement provides an update on the progress of the PANORAMIC study for evaluating new antivirals against COVID-19, particularly focusing on molnupiravir.

Action Requested

MPs are requested to encourage their constituents to participate in the PANORAMIC trial by signing up online or through a freephone number. The Department will publish further updates as more data becomes available.

Key Facts

  • The PANORAMIC study was launched on 8 December 2021.
  • Recruitment of 3,176 participants has been achieved as of noon on 12 January 2022.
  • Participants must be over 50 years old or over 18 with certain underlying health conditions and have received a positive test for COVID-19 within the last five days.
  • Molnupiravir was granted conditional Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency on 4 November 2021.
Assessment & feedback
Summary accuracy